Upventa Biosciences Private Limited - Company Profile

It is a paper private limited company based in New Delhi, Delhi, India, established in 2023.
2023 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Upventa Biosciences Private Limited

Upventa Biosciences Private Limited, a active private limited company, was established on 28 March 2023 in New Delhi, Delhi, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21003DL2023PTC411696. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Uma Sethi (Director), Nitin Raj Bhasin (Director), Alok Saxena (Director). It is based at Plot No. F-7 Block F, Mayapuri Phase Ii, New Delhi, Delhi, 110064.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21003DL2023PTC411696

  • Registration Number

    411696

  • Incorporation Date

    28 March 2023

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 2 Year, 11 Months
Company report

Upventa Biosciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Upventa Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Upventa Biosciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Uma Sethi Director 28 Mar 2023 Current
Nitin Raj Bhasin Director 28 Mar 2023 Current
Alok Saxena Director 28 Mar 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Upventa Biosciences.

Enhance accessibility to Upventa Biosciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Upventa Biosciences revenue growth over time
Upventa Biosciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Upventa Biosciences?

Unlock access to Upventa Biosciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Upventa Biosciences?

Unlock and access historical data on people associated with Upventa Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Upventa Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Upventa Biosciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Upventa Biosciences
Recent Activity within the Organization
  • Director Appointment

    Progress on Uma Sethi was appointed as a Director was appointed as a Director on 28 Mar 2023 & has been associated with this company since 2 years 11 months . was documented.

  • Director Appointment

    The activity Nitin Raj Bhasin was appointed as a Director was appointed as a Director on 28 Mar 2023 & has been associated with this company since 2 years 11 months . was completed.

  • Director Appointment

    Progress on Alok Saxena was appointed as a Director was appointed as a Director on 28 Mar 2023 & has been associated with this company since 2 years 11 months . was documented.

  • Company Incorporation

    The activity Upventa Biosciences Private Limited was registered on 28 Mar 2023 with Roc Delhi & aged 2 years 11 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Upventa Biosciences Private Limited?

The CIN of Upventa Biosciences Private Limited is U21003DL2023PTC411696.

Where is Upventa Biosciences Private Limited headquartered?

Upventa Biosciences Private Limited is headquartered at Plot No. F-7 Block F, Mayapuri Phase Ii, New Delhi, Delhi, 110064.

When was Upventa Biosciences Private Limited incorporated?

Upventa Biosciences Private Limited was incorporated on 28 March 2023.

Who are the current directors of Upventa Biosciences Private Limited?

The current directors of Upventa Biosciences Private Limited are

What is the primary industry of Upventa Biosciences Private Limited?

The primary industry of Upventa Biosciences Private Limited is Paper.

Is Upventa Biosciences Private Limited a listed company?

Upventa Biosciences Private Limited is unlisted.

What is the capital structure of Upventa Biosciences Private Limited?

The authorized capital of Upventa Biosciences Private Limited is ₹1.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available